James Clark on Muck Rack

James Clark

Tennessee
As seen in: Medium, Bloomberg Opinion, Color Research & Application, Wiley Online Library, Daily Star (UK), MDPI, TechRadar, U.S. News and World Report, JAMA Network, Scottish Daily Record and
Editor of the Southern Standard Newspaper in McMinnville, Tennessee
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with James

Contact James, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

I'm back

|
By James Clark
| Herald-Citizen Verified
I’m back! It’s been nearly four years since I last wrote an article for this fine, hometown newspaper so forgive me if I’m a little rusty. It may take a few stories to regain my polish. The last time we talked, I was saying goodbye to newspaper work and saying hello to teaching. I’m still in the early phases of my teaching career, just finishing my fourth year in the classroom. Teachers like to talk about reaching the magical 30-year plateau when they can sail off into retirement.
Open in Who Shared Issue with article?

The hidden delays costing the NHS £1bn a year

|
By James Clark
| Business Age
Opinion By By James Clark “We have to get more out of the NHS for what we put in.” Thus spoke Wes Streeting in March this year. His words were a reference back to the NHS’ Ten-Year Health Plan, which is perhaps more focused on productivity than any other metric. NHS trusts across the country have been tasked with reaching a productivity increase of 2% year-on-year. It has so far slightly overachieved this target, with an increase of 2.7% over the past year.
Open in Who Shared Issue with article?

Remove Oral Diphenhydramine from OTC

|
By James Clark
| JAMA Network Verified
Diphenhydramine, a first-generation antihistamine, was approved by the US Food and Drug Administration (FDA) in 1946 for the treatment of allergies and in 1982 was authorized for over-the-counter (OTC) sales.1 Since that time, many millions of patients with allergies have benefited from its therapeutic efficacy. However, diphenhydramine’s benefits are offset by substantial neurologic and anticholinergic adverse reactions.
Open in Who Shared Issue with article?
See all 1,967 licensed articles (2,006 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified